India to United States: Mycophenolate Export Trade Route
India has recorded 625 verified shipments of Mycophenolate exported to United States, representing a combined trade value of $232.5M USD. This corridor is served by 18 active Indian exporters, with an average shipment value of $372.1K USD. The leading Indian exporter is INTAS PHARMACEUTICALS LIMITED, which accounts for 74% of total export value with 121 shipments worth $171.9M USD. On the buying side, EVERSANA LIFE SCIENCES SERVICES,LLC is the largest importer in United States with $166.8M USD in purchases. The top 3 suppliers — INTAS PHARMACEUTICALS LIMITED, STRIDES PHARMA SCIENCE LIMITED, SANDOZ PRIVATE LIMITED — together control 92% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to United States Mycophenolate corridor is one of India's established pharmaceutical export routes, with 625 shipments documented worth a combined $232.5M USD. The route is dominated by INTAS PHARMACEUTICALS LIMITED, which alone accounts for roughly 74% of all export value, reflecting the consolidated nature of India's mycophenolate manufacturing sector.
Across 18 active suppliers, the average shipment value stands at $372.1K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 83% of all shipments, consistent with mycophenolate's non-urgent bulk-order profile.
Shipment activity peaks during October–December, with an average transit time of 29 days port-to-port. The route has recorded an annual growth rate of 26.0%, placing it at rank #16 among India's top mycophenolate export destinations globally.
On the import side, key buyers of Indian mycophenolate in United States include EVERSANA LIFE SCIENCES SERVICES,LLC, STRIDES PHARMA INC,, STRIDES PHARMA INC and 36 others. EVERSANA LIFE SCIENCES SERVICES,LLC is the single largest importer with 68 shipments valued at $166.8M USD.
Route Characteristics
- Average transit29 days
- Peak seasonQ4
- Primary modeSea freight
- Top portSAHAR AIR
Market Position
- Global rank#16
- Annual growth+26.0%
- Demand growth+21.9%
- Regulatory ease87/100
Top 10 Indian Mycophenolate Exporters to United States
Showing top 10 of 18 Indian suppliers exporting Mycophenolate to United States, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | INTAS PHARMACEUTICALS LIMITED Avg $1.4M per shipment | 121 | $171.9M | 73.9% |
| 2 | STRIDES PHARMA SCIENCE LIMITED Avg $188.6K per shipment | 155 | $29.2M | 12.6% |
| 3 | SANDOZ PRIVATE LIMITED Avg $173.3K per shipment | 70 | $12.1M | 5.2% |
| 4 | ALKEM LABORATORIES LIMITED Avg $85.9K per shipment | 122 | $10.5M | 4.5% |
| 5 | CONCORD BIOTECH LIMITED Avg $64.9K per shipment | 93 | $6.0M | 2.6% |
| 6 | MYLAN LABORATORIES LIMITED Avg $78.6K per shipment | 13 | $1.0M | 0.4% |
| 7 | INTAS PHARMACEUTICALS LTD Avg $101.8K per shipment | 7 | $712.8K | 0.3% |
| 8 | ALKEM LABORATORIES LTD Avg $101.0K per shipment | 6 | $605.8K | 0.3% |
| 9 | ONESOURCE SPECIALTY PHARMA LIMITED Avg $64.4K per shipment | 5 | $322.2K | 0.1% |
| 10 | CONCORD BIOTECH LTD Avg $37.8K per shipment | 2 | $75.5K | 0.0% |
This table shows the top 10 of 18 Indian companies exporting mycophenolate to United States, ranked by total trade value. The listed exporters are: INTAS PHARMACEUTICALS LIMITED, STRIDES PHARMA SCIENCE LIMITED, SANDOZ PRIVATE LIMITED, ALKEM LABORATORIES LIMITED, CONCORD BIOTECH LIMITED, MYLAN LABORATORIES LIMITED, INTAS PHARMACEUTICALS LTD, ALKEM LABORATORIES LTD, ONESOURCE SPECIALTY PHARMA LIMITED, CONCORD BIOTECH LTD. INTAS PHARMACEUTICALS LIMITED is the dominant supplier with 121 shipments worth $171.9M USD, giving it a 74% market share. The top 3 suppliers together account for 92% of the total trade value on this route.
Showing top 10 of 18 total Indian exporters on the India to United States Mycophenolate export route.
Top 10 Mycophenolate Importers in United States
Showing top 10 of 39 known buyers in United States receiving Mycophenolate shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian mycophenolate in United States include EVERSANA LIFE SCIENCES SERVICES,LLC, STRIDES PHARMA INC,, STRIDES PHARMA INC, SANDOZ INC C O EXEL INC, ASCEND LABORATORIES,LLC, among 39 total buyers. The largest importer is EVERSANA LIFE SCIENCES SERVICES,LLC, accounting for $166.8M USD across 68 shipments — representing 72% of all mycophenolate imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | EVERSANA LIFE SCIENCES SERVICES,LLC | 68 | $166.8M | 71.7% |
| 2 | STRIDES PHARMA INC, | 63 | $13.9M | 6.0% |
| 3 | STRIDES PHARMA INC | 56 | $9.7M | 4.2% |
| 4 | SANDOZ INC C O EXEL INC | 38 | $6.3M | 2.7% |
| 5 | ASCEND LABORATORIES,LLC | 70 | $6.0M | 2.6% |
| 6 | SANDOZ INC. C/O EXEL, INC. | 29 | $5.0M | 2.2% |
| 7 | TO THE ORDER | 83 | $5.0M | 2.1% |
| 8 | ASCEND LABORATORIES LLC | 52 | $4.5M | 2.0% |
| 9 | EVERSANA LIFE SCIENCES SERVICES LLC | 29 | $3.3M | 1.4% |
| 10 | AVET PHARMACCEUTICALS INC., | 21 | $2.7M | 1.2% |
Showing top 10 of 39 Mycophenolate importers in United States on this route.
Top 10 Mycophenolate Formulations Imported by United States
Showing top 10 of 348 product formulations shipped on the India to United States Mycophenolate route, ranked by trade value
United States imports a wide range of mycophenolate formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — PHA.DRU & MEDI, MYCOPHENOLATE MOFETIL USP 500MG500T(US) MYCOPHENOLATE MOFETIL T500MG EACH FILM COATED TABLET CONTAINS — accounts for $150.3M USD across 2 shipments. There are 348 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | PHA.DRU & MEDI, MYCOPHENOLATE MOFETIL USP 500MG500T(US) MYCOPHENOLATE MOFETIL T500MG EACH FILM COATED TABLET CONTAINS | 2 | $150.3M | 64.6% |
| 2 | PHA.DRU & MEDI, MYCOPHENOLATE MOFETIL USP 500MG100T(US) MYCOPHENOLATE MOFETIL T500MG EACH FILM COATED TABLET CONTAINS | 1 | $10.0M | 4.3% |
| 3 | MYCOPHENOLATE MOF 500MG 100FCT BO US MAT | 9 | $1.6M | 0.7% |
| 4 | Mycophenolate Mofetil Tablets USP [500mg | 8 | $1.6M | 0.7% |
| 5 | MYCOPHENOLATE MOF 500MG 100FCT BO US, MATERIAL NO. - 44014700 | 4 | $1.5M | 0.6% |
| 6 | PHA.DRU & MEDI, MYCOPHENOLATE MOFETIL US | 6 | $1.3M | 0.5% |
| 7 | PHARMA DRUGS & MEDI MYCOPHENOLATE MOFETIL USP 500MG500T(US) AS PER INVOICE | 11 | $1.1M | 0.5% |
| 8 | PHARMACEUTICAL PRODUCTS : MYCOPHENOLATEMOF.TABLETS USP 500MG(100) NDC No67877022501 | 9 | $1.1M | 0.5% |
| 9 | MYCOPHENOLATE MOF 500MG 100FCT BO US MATERIAL NO. - 44014700 | 5 | $965.0K | 0.4% |
| 10 | MYCOPHENOLATE MOFETIL TABLETS USP 500MG FC US EACH FILM COATED TABLET CONTAINS MYCOPHENOLATE MOFETIL USP 500MG | 3 | $823.3K | 0.4% |
Showing top 10 of 348 Mycophenolate formulations imported by United States on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 83%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
SAHAR AIR handles the highest volume with 91 shipments. Transit time averages 29 days by sea.
Market Dynamics
India's mycophenolate exports to United States are driven primarily by a handful of large-scale manufacturers. INTAS PHARMACEUTICALS LIMITED with 121 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 18 active exporters signals a competitive but concentrated market — buyers in United States benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — INTAS PHARMACEUTICALS LIMITED, STRIDES PHARMA SCIENCE LIMITED, SANDOZ PRIVATE LIMITED — together account for 92% of total trade value on this route. The average shipment value of $372.1K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.
Beyond the primary product category, shipments on this route include closely related formulations such as pha.dru & medi, mycophenolate mofetil usp 500mg100t(us) mycophenolate mofetil t500mg each film coated tablet contains and mycophenolate mof 500mg 100fct bo us mat, suggesting that buyers in United States tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, EVERSANA LIFE SCIENCES SERVICES,LLC is the largest importer with 68 shipments worth $166.8M USD — representing 72% of all mycophenolate imports from India on this route. A total of 39 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $232.5M
- Avg. Shipment
- $372.1K
- Suppliers
- 18
- Buyers
- 39
- Transit (Sea)
- ~29 days
- Annual Growth
- +26.0%
Related Analysis
Reverse Direction
United States → India — Mycophenolate (Import)Other Mycophenolate Routes
Unlock the Full India to United States Mycophenolate Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 625 shipments on this route.
Frequently Asked Questions — India to United States Mycophenolate Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Mycophenolate to United States?
The leading Indian exporters of Mycophenolate to United States are INTAS PHARMACEUTICALS LIMITED, STRIDES PHARMA SCIENCE LIMITED, SANDOZ PRIVATE LIMITED. INTAS PHARMACEUTICALS LIMITED holds the largest market share at approximately 74% of total trade value on this route.
Q What is the total value of Mycophenolate exports from India to United States?
India exports Mycophenolate to United States worth approximately $232.5M USD across 625 recorded shipments. The average value per shipment is $372.1K USD.
Q Which ports does India use to ship Mycophenolate to United States?
The most active port of origin is SAHAR AIR with 91 shipments. Indian exporters primarily use sea freight for this route, with 83% of shipments going by sea and 28% by air.
Q How long does shipping take from India to United States for Mycophenolate?
The average transit time for Mycophenolate shipments from India to United States is approximately 29 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during October–December.
Q Is the India to United States Mycophenolate trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 26.0% with demand growth tracking at 21.9%. The route is ranked #16 among India's top Mycophenolate export destinations globally.
Q How many suppliers are active on the India to United States Mycophenolate route?
There are currently 18 active Indian suppliers exporting Mycophenolate to United States. The market is moderately concentrated with INTAS PHARMACEUTICALS LIMITED accounting for 74% of total shipment value.
Q Who are the main importers of Mycophenolate from India in United States?
The leading importers of Indian Mycophenolate in United States include EVERSANA LIFE SCIENCES SERVICES,LLC, STRIDES PHARMA INC,, STRIDES PHARMA INC, SANDOZ INC C O EXEL INC, ASCEND LABORATORIES,LLC. EVERSANA LIFE SCIENCES SERVICES,LLC is the largest buyer with 68 shipments worth $166.8M USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to United States export trade corridor identified from Indian Customs (DGFT) records for Mycophenolate.
- 2.Supplier/Buyer Matching: 18 Indian exporters and 39 importers in United States matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 625 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
625 Verified Shipments
18 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists